JPMorgan Chase & Co. Lowers Rentokil Initial (LON:RTO) Price Target to GBX 430

Rentokil Initial (LON:RTOGet Free Report) had its price target reduced by equities research analysts at JPMorgan Chase & Co. from GBX 440 ($5.38) to GBX 430 ($5.26) in a research note issued on Tuesday,Digital Look reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 13.91% from the company’s current price.

Rentokil Initial Stock Down 1.3 %

Shares of LON RTO traded down GBX 5.10 ($0.06) during midday trading on Tuesday, reaching GBX 377.50 ($4.62). The company’s stock had a trading volume of 3,039,990 shares, compared to its average volume of 75,605,219. The company has a current ratio of 1.04, a quick ratio of 1.76 and a debt-to-equity ratio of 116.58. Rentokil Initial has a fifty-two week low of GBX 336.30 ($4.12) and a fifty-two week high of GBX 517.60 ($6.33). The stock has a market capitalization of £9.48 billion, a price-to-earnings ratio of 2,359.38, a PEG ratio of 0.56 and a beta of 0.55. The stock has a 50 day simple moving average of GBX 398.73 and a 200-day simple moving average of GBX 422.88.

Insiders Place Their Bets

In other Rentokil Initial news, insider Brian Baldwin bought 7,500,000 shares of Rentokil Initial stock in a transaction dated Wednesday, December 11th. The stock was bought at an average price of GBX 413 ($5.05) per share, with a total value of £30,975,000 ($37,903,817.91). Company insiders own 0.32% of the company’s stock.

Rentokil Initial Company Profile

(Get Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Read More

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.